Young and Aged Blunt Trauma Patients Display Major Differences in Circulating Inflammatory Mediator Profiles after

Ashley J Lamparello1, Rami A Namas2, Othman Abdul-Malak1

  • 1Department of Surgery, University of Pittsburgh, Pittsburgh, PA.

Insights

Aging trauma patients show distinct inflammatory profiles, with higher levels of specific chemokines (CXCL10, CXCL9) and complex networks, not just suppressed inflammation.

Area of Science:

  • Immunology
  • Trauma Research
  • Gerontology

Background:

  • Aging alters immune function, impacting inflammatory responses.
  • The inflammatory mediator network post-severe trauma in aged individuals is not well understood.
  • Severe trauma triggers complex immune responses that may differ significantly with age.

Purpose of the Study:

  • To compare time-dependent changes in inflammatory biomarkers and network expression in young versus aged trauma patients.
  • To characterize age-related differences in circulating inflammatory mediators after severe blunt trauma.
  • To investigate the complexity of inflammatory networks in young and aged trauma cohorts.

Main Methods:

  • Analysis of 30 inflammatory biomarkers in plasma from young and aged blunt trauma patients.
  • Plasma samples collected multiple times within the first 24 hours and daily for 7 days.
  • Statistical analysis including 2-way ANOVA, AUC, Dynamic Bayesian Network, and Dynamic Network Analysis on matched cohorts.

Main Results:

  • Younger trauma patients had higher Injury Severity Scores and elevated levels of 18 inflammatory mediators.
  • Aged trauma patients exhibited higher levels of C-X-C motif chemokine ligand 10 (CXCL10) and C-X-C motif chemokine ligand 9 (CXCL9).
  • Matched cohorts confirmed persistent higher CXCL10 and CXCL9 levels in aged individuals, with greater network complexity.

Conclusions:

  • Age-related inflammatory responses to trauma are characterized by a shift in mediator profiles, not just suppressed inflammation.
  • Specific chemokines like CXCL10 and CXCL9 are key mediators in aged trauma patients.
  • Inflammatory network complexity increases with age following severe trauma.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
237
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
254
Major Organs of the Digestive System01:19

Major Organs of the Digestive System

The digestive system is responsible for the ingestion of food, secretion of enzymes, mixing and digesting food, absorption of the nutrients and defecation. The human digestive system consists of two major parts: the gastrointestinal tract and the accessory digestive organs.
Gastrointestinal tract:
9.5K